Table 1

Characteristics of the sample [chart review and SOS part 5 (health habits), 6 (past sleep history) & 7 (medical history)]
All (N = 249) Frequency Percentage
Male 151 60.2
Mean Std
Age in years 59.6 12.1
Years since RTx 11.1 7.0
Body Mass Index (kg/m2) 25.9 5.2
Creatinine (μmol/l) 125.0 81.6
Haemoglobin (g/l) 127.6 16.5
Median (25Q-75Q)
Charlson Comorbidities Index 1 0-2
Immunosuppressive drugs Frequency Percentage
Cyclosporin 103 41.4
Tacrolimus 93 37.3
Sirolimus, Everolimus 23 9.2
Mycophenolat 152 61.0
Azathioprine 38 15.3
Corticosteroids 78 31.3
Co-medication chart review
Statin 97 39.0
ACE inhibitor 61 24.5
Angiotensin receptor blocker 68 27.3
Calcium channel blocker 43 17.3
Beta blocker 92 36.9
Anticoagulants 58 23.3
Antidepressants 14 5.6
Diuretics 42 16.9
Sleep drugs 9 3.6
Self-reported sleep drug use 82 32.9
Caffeine use (>2 cups/d) 132 62.3
Nicotine use 31 12.4
Alcohol use (>1 glass/day) 64 25.8
Sleep history in childhood
Insomnia 24 9.6
Sleepwalking 16 6.4
Bed-wetting 24 9.6
Talking in your sleep 29 11.6
Nightmares 21 8.4
Night terrors (screaming in the middle of the night and being difficult to awaken) 6 2.4
Head-banging or body rocking 8 3.2
Seizures during sleep, while falling asleep, or while waking up 5 2.0
Daytime sleepiness 12 4.8
Snoring 12 4.8
Breathing difficulties 5 2.0

Burkhalter et al.

Burkhalter et al. BMC Nephrology 2013 14:220   doi:10.1186/1471-2369-14-220

Open Data